Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis (Q35872734)

10 August 2017

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis (English)

1 reference

10 August 2017

1 reference

Emad A Rakha

3

0 references

Ian Ellis

object named as

Ian O Ellis

series ordinal

7

0 references

Sarah E. Pinder

series ordinal

6

object named as

Sarah E Pinder

1 reference

10 August 2017

2

Dalia M Abd El-Rehim

1 reference

10 August 2017

4

Claire E Paish

1 reference

10 August 2017

Thomas C Putti

1

1 reference

PubMed ID

15332092

10 August 2017

Andrew H S Lee

series ordinal

5

1 reference

10 August 2017

1 January 2005

1 reference

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

1

1 reference

10 August 2017

26-35

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800255

10 August 2017

0 references

cites work

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Adenoid cystic carcinoma of the breast: a tumour commonly devoid of oestrogen receptors and related proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Prognostic comparison of three classifications for medullary carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

The Nottingham prognostic index in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Salivary gland-like tumours of the breast: surgical and molecular pathology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Molecular classification of primary breast tumors possessing distinct prognostic properties

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Factors influencing local recurrence after excision and radiotherapy for primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

c-erbB-2 expression in different histological types of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

E-cadherin expression in primary carcinomas of the breast and its distant metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800255

7 January 2021

10.1038/MODPATHOL.3800255

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15332092